Mutations in PIK3CA are amongst the most frequently detected mutations in cervical cancer [69], but other alterations that result in the aberrant PI3K/AKT/mTOR activation, for instance genomic amplifications of PIK3CA [74,75] or the loss of PTEN [69], are also reported. This evidence concerns the gene PIK3CA and cervical cancer.